Isookanin Anti-Inflammatory Composition With Low Skin Irritation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for inflammatory diseases, such as atopic dermatitis, psoriasis, acne, edema, rosacea, sunburn, rheumatoid arthritis, and inflammatory bowel disease, face challenges in effectively inhibiting inflammation and angiogenesis while minimizing side effects like skin irritation and cytotoxicity.
Innovation Solution
A composition containing isookanin or its salt is developed to inhibit Janus kinases, toll-like receptor-2 signaling, cyclooxygenase-2 activity, and epidermal protease kallikrein-5, thereby reducing excessive immune responses and prostaglandin production, which are key factors in inflammatory diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If NSAIDs are used to treat inflammatory diseases by inhibiting COX enzymes, then anti-inflammatory effect is improved, but gastrointestinal side effects worsen
Solution Approach 1:
The invention segments the COX enzyme inhibition function into selective COX-2 inhibition, separating the therapeutic anti-inflammatory effect from the harmful gastrointestinal side effects that result from non-selective COX-1 and COX-2 inhibition by traditional NSAIDs
Solution Approach 2:
The invention applies local quality by designing compounds with selective affinity for COX-2 enzyme isoform while sparing COX-1, thereby concentrating the anti-inflammatory effect where it is needed (inflammatory sites with elevated COX-2) while avoiding harm to gastrointestinal prostaglandin protection
2Reliability
If existing treatments are used to inhibit inflammation and angiogenesis, then therapeutic effect is improved, but skin irritation and cytotoxicity worsen
Solution Approach 1:
The invention changes the chemical structure parameters of flavonoid compounds (specifically introducing the isookanin structure with particular hydroxyl group positions and methoxy substitution) to achieve selective inhibition of inflammatory and angiogenic pathways while reducing cytotoxicity compared to conventional treatments
Solution Approach 2:
The invention uses isookanin as a natural compound intermediary that mediates inhibition of multiple pathological pathways (inflammation, angiogenesis) through natural product chemistry, providing a safer alternative to synthetic drugs with harsher side effect profiles
Data Source
AI summary
The present invention relates to a composition for preventing, improving, or treating inflammatory disease containing isookanin or a salt thereof as an active ingredient. The composition containing the isookanin or salt thereof as an active ingredient according to the present invention has no skin irritation and cytotoxicity, and thus has excellent safety for the human body. In addition, it has excellent effects on the inhibition of JAK1 activity, kallikrein-5 activity, TLR-2 activation, COX-2 expression and activity, prostaglandin PGE2 production, and PGE2-induced angiogenesis, and thus is very effective in preventing, alleviating and treating inflammatory disease. Accordingly, the composition containing the isookanin or salt thereof as an active ingredient according to the present invention may be useful as an active ingredient in a cosmetic composition, a pharmaceutical composition, a composition for skin application and a quasi-drug composition for preventing, alleviating or treating inflammatory disease.